企業プロフィール
OpGen 株価・ニュース・カタリスト
- ティッカー:
- OPGN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for OPGN.
企業概要
事業概要
OpGen was a molecular diagnostics company focused on infectious disease and rapid genomic testing before becoming a historical ticker. Its business centered on helping clinicians identify pathogens and resistance faster.
所在地とセクター分類
OpGen was headquartered in the United States and traded on NASDAQ. It sat in diagnostics and molecular testing.
ビジネスモデルの特徴
The company depended on test adoption, commercialization, and hospital workflow integration. Investors historically watched revenue, reimbursement, and operational execution.
バイオ業界での位置付け
OpGen belongs to the historical diagnostics infrastructure category. It is not a drug stock, but it supported the testing ecosystem that informs patient care.
今後のカタリスト
- OpGen is a legacy / closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on residual value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。